EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY-NC 4.0

Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation

Eva Schuijt, Daniel Scherr iD, Gernot Plank iD, Ulrich Schotten iD, Jordi Heijman iD

Europace · 2024

DOI: 10.1093/europace/euae304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Europace, 2024. Verfasst von Eva Schuijt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anti-Arrhythmia Agents, Catheter Ablation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Netherlands Heart Foundation, Electro-Molecular Basis and the Rapeutic management of Atrial Cardiomyopathy, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 1924, the Dutch physiologist Willem Einthoven received the Nobel Prize in Physiology or Medicine for his discovery of the mechanism of the electrocardiogram (ECG). Anno 2024, the ECG is commonly used as a diagnostic tool in cardiology. In the paper ‘Le Télécardiogramme’, Einthoven described the first recording of the now most common cardiac arrhythmia: atrial fibrillation (AF). The treatment of AF includes rhythm control, aiming to alleviate symptoms and improve quality of life. Recent studies found that early rhythm control might additionally improve clinical outcomes. However, current therapeutic options have suboptimal efficacy and safety, highlighting a need for better rhythm-control strategies. In this review, we address the challenges related to antiarrhythmic drugs (AADs) and catheter ablation for rhythm control of AF, including significant recurrence rates and adverse side effects such as pro-arrhythmia. Furthermore, we discuss potential solutions to these challenges including novel tools, such as atrial-specific AADs and digital-twin-guided AF ablation. In particular, digital twins are a promising method to integrate a wide range of clinical data to address the heterogeneity in AF mechanisms. This may enable a more mechanism-based tailored approach that may overcome the limitations of previous precision medicine approaches based on individual biomarkers. However, several translational challenges need to be addressed before digital twins can be routinely applied in clinical practice, which we discuss at the end of this narrative review. Ultimately, the significant advances in the detection, understanding, and treatment of AF since its first ECG documentation are expected to help reduce the burden of this troublesome condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnti-Arrhythmia AgentsCatheter AblationHumansHistory, 20th CenturyElectrocardiographyTranslational Research, BiomedicalHistory, 21st CenturyDiffusion of InnovationHeart RateElectrophysiologic Techniques, CardiacAction Potentials

Stichwörter der Autor:innen

AblationAntiarrhythmic drugsAtrial fibrillationDigital twinsPrecision medicineRhythm control

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Physiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
  • Department of Cardiology, Medical University of Graz, Graz, Austria.
  • Division of Medical Physics and Biophysics, Gottfried Schatz Research Center, Medical University of Graz, Neue Stiftingtalstr. 6, 8010 Graz, Austria.
  • Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University and Maastricht University Medical Center, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.

ORCID-Profile: Daniel Scherr, Gernot Plank, Ulrich Schotten, Jordi Heijman

Förderung

  • Netherlands Heart Foundation
  • Electro-Molecular Basis and the Rapeutic management of Atrial Cardiomyopathy
  • European Union
  • Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation
  • Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment
  • Netherlands Organisation for Scientific Research

Zitieren

APA

Schuijt, E., Scherr, D., Plank, G., Schotten, U., & Heijman, J. (2024). Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. Europace. https://doi.org/10.1093/europace/euae304

Vancouver

Schuijt E, Scherr D, Plank G, Schotten U, Heijman J. Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. Europace. 2024. doi:10.1093/europace/euae304

BibTeX
@article{Schuijt2024,
  author = {Schuijt, Eva and Scherr, Daniel and Plank, Gernot and Schotten, Ulrich and Heijman, Jordi},
  title = {Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae304}
}
Kostenlos starten →